HR
AZN icon

Hardy Reed’s AstraZeneca AZN Stock Holding History

Hardy Reed’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Sell
2,496
-6
-0.2% -$1.13K 0.03% 158
2026
Q1 		$493K Buy
2,502
+601
+32% +$116K 0.04% 145
2025
Q4 		$349K Buy
1,901
+52
+3% +$9.12K 0.02% 182
2025
Q3 		$284K Buy
1,849
+180
+11% +$27.2K 0.02% 200
2025
Q2 		$233K Buy
1,669
+37
+2% +$5.19K 0.02% 221
2025
Q1 		$240K Buy
1,632
+36
+2% +$5.21K 0.02% 209
2024
Q4 		$209K Buy
1,596
+5
+0.3% +$700 0.02% 240
2024
Q3 		$248K Buy
1,591
+89
+6% +$14.4K 0.02% 213
2024
Q2 		$234K Buy
+1,502
New +$226K 0.02% 207

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hardy Reed's AZN Position: Q2 2026 in Review

Hardy Reed reduced its AstraZeneca (AZN) stake by 0.24% in Q2 2026, selling an estimated $1.13K and leaving 2,496 shares worth $473K. The position accounts for 0.03% of the portfolio, ranked #158.

Hardy Reed first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $493K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hardy Reed held 2,496 shares of AstraZeneca worth $473K as of Q2 2026.
  • Hardy Reed sold 6 AstraZeneca shares in Q2 2026, an estimated $1.13K.
  • AstraZeneca made up 0.03% of Hardy Reed's portfolio in Q2 2026, its #158 holding.
  • Hardy Reed first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • Hardy Reed's AstraZeneca position peaked at $493K in Q1 2026.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.